semaglutide and opiates may reduce opioid overdoses, a new study suggests Could drugs like Ozempic help

GLA-KO human kidney organoids recapitulate human renal Fabry disease and might be valuable tools for studying the mechanisms and for the development of novel therapeutic alternatives for Fabry disease

Research suggests that combined GIP and GLP-1 activation produces synergistic rather than merely additive effects on appetite and reward processing

These difficulties have been partially alleviated throughout the past few years as a result of significant advancements in our knowledge of forms of ASD that are caused by single-gene abnormalities, such as tuberous sclerosis and fragile X syndrome

This is why comprehensive gut testing becomes crucial for anyone currently using or those planning to discontinue GLP-1 medications

Edmond J Safra Foundation (to TF)